Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease.
Atherosclerosis is the underlying reason for nearly all causes of coronary artery disease and peripheral arterial disease and many cases of stroke. Atherosclerosis is a systemic inflammatory process characterised by the accumulation of lipids and macrophages/lymphocytes within the intima of large arteries. The deposition of these blood borne materials and the subsequent thickening of the wall often significantly compromise the residual lumen leading to ischaemic events distal to the arterial stenosis. However, these initial fatty streak lesions may also evolve into vulnerable plaques susceptible to rupture or erosion. Plaque disruption initiates both platelet adhesion and aggregation on the exposed vascular surface and the activation of the clotting cascade leading to the so-called atherothrombotic process. Yet, platelets have also been shown to be transporters of regulatory molecules (micro-RNA), to drive the inflammatory response and mediate atherosclerosis progression. Here we discuss our current understanding of the pathophysiological mechanisms involved in atherogenesis - from fatty streaks to complex and vulnerable atheromas - and highlight the molecular machinery used by platelets to regulate the atherogenic process, thrombosis and its clinical implications.
Cardiovascular Research Center, CSIC-ICCC, HSCSP, Barcelona, Spain ; CIBER OBN -Instituto Salud Carlos III, Madrid, Spain ; Cardiovascular Research Chair, UAB, Barcelona, Spain.
Lina
L
Badimon
Teresa
T
Padró
Gemma
G
Vilahur
Atherosclerosis; platelets; thrombosis; vulnerable atherosclerotic plaque